Abstract
This study examines how a high false-positive rate in lung cancer screening influences the harm-to-benefit ratio for higher- vs lower-risk patients.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Early Detection of Cancer / statistics & numerical data*
-
False Positive Reactions
-
Humans
-
Incidence
-
Lung Neoplasms / diagnostic imaging*
-
Lung Neoplasms / epidemiology
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Neoplasm Staging / methods
-
Solitary Pulmonary Nodule / diagnostic imaging*
-
Solitary Pulmonary Nodule / epidemiology
-
Solitary Pulmonary Nodule / pathology
-
United States
-
United States Department of Veterans Affairs
-
Veterans / statistics & numerical data*
-
Veterans Health / standards